Related Experiment Video

Updated: Jul 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Lowering LDL cholesterol. How much is enough?]

W März1, T B Grammer

  • 1Synlab Medizinisches Versorgungszentrum für Labordiagnostik Heidelberg, Heidelberg, Deutschland. maerz@synlab.de

Der Internist
|March 3, 2007
PubMed

Insights

Lowering LDL cholesterol (LDL-C) significantly reduces cardiovascular risk, especially for high-risk patients. Lipid-lowering therapy is most effective when tailored to individual patient risk levels for arteriosclerosis prevention.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Arteriosclerosis Research

Context:

  • Arteriosclerosis presents a significant health challenge, with cholesterol management being a key principle in its prevention and treatment.
  • Lipid-lowering pharmacotherapy effectiveness is directly correlated with individual patient risk.
  • Therapeutic decisions for lipid management are guided by a comprehensive assessment of the patient's overall risk profile.

Purpose:

  • To outline the established benefits of reducing cholesterol and low-density lipoprotein cholesterol (LDL-C) in managing arteriosclerosis.
  • To define target LDL-C levels for different patient populations, including those with acute coronary syndrome, diabetes mellitus, and stable coronary heart disease.
  • To discuss the role of diabetes mellitus as a potential coronary risk equivalent.

Summary:

  • Significant reduction of LDL-C to approximately 70 mg/dl over time can decrease coronary event risk by two-thirds.
  • For patients with acute coronary syndrome and/or diabetes mellitus, an LDL-C target of 70 mg/dl is clinically justified.
  • For patients with stable coronary heart disease, aiming for an LDL-C level of 100 mg/dl or lower is recommended.
  • The classification of diabetes mellitus as a "coronary risk equivalent" warranting an LDL-C reduction to 100 mg/dl or less remains a subject of debate.

Impact:

  • Provides clear targets for LDL-C reduction to mitigate arteriosclerosis and coronary events.
  • Informs clinical decision-making regarding the intensity of lipid-lowering pharmacotherapy based on patient risk stratification.
  • Highlights areas for further research regarding the precise management of dyslipidemia in diabetic patients.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...